JP2014517028A5 - - Google Patents

Info

Publication number
JP2014517028A5
JP2014517028A5 JP2014515299A JP2014515299A JP2014517028A5 JP 2014517028 A5 JP2014517028 A5 JP 2014517028A5 JP 2014515299 A JP2014515299 A JP 2014515299A JP 2014515299 A JP2014515299 A JP 2014515299A JP 2014517028 A5 JP2014517028 A5 JP 2014517028A5
Authority
JP
Japan
Prior art keywords
composition
oil
emulsion
drug
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014515299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014517028A (ja
JP5864735B2 (ja
Filing date
Publication date
Priority claimed from US13/161,101 external-priority patent/US8895074B2/en
Application filed filed Critical
Priority claimed from PCT/IB2012/001156 external-priority patent/WO2012172411A1/en
Publication of JP2014517028A publication Critical patent/JP2014517028A/ja
Publication of JP2014517028A5 publication Critical patent/JP2014517028A5/ja
Application granted granted Critical
Publication of JP5864735B2 publication Critical patent/JP5864735B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014515299A 2011-06-15 2012-06-13 非経口オキアミ油の治療用途 Expired - Fee Related JP5864735B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/161,101 US8895074B2 (en) 2011-06-15 2011-06-15 Therapeutic application of parenteral krill oil
US13/161,101 2011-06-15
EP11179821 2011-09-02
EP11179821.1 2011-09-02
PCT/IB2012/001156 WO2012172411A1 (en) 2011-06-15 2012-06-13 Therapeutic application of parenteral krill oil

Publications (3)

Publication Number Publication Date
JP2014517028A JP2014517028A (ja) 2014-07-17
JP2014517028A5 true JP2014517028A5 (enExample) 2015-07-30
JP5864735B2 JP5864735B2 (ja) 2016-02-17

Family

ID=46456944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014515299A Expired - Fee Related JP5864735B2 (ja) 2011-06-15 2012-06-13 非経口オキアミ油の治療用途

Country Status (22)

Country Link
EP (1) EP2720701B1 (enExample)
JP (1) JP5864735B2 (enExample)
KR (1) KR101841588B1 (enExample)
CN (2) CN107648268B (enExample)
BR (1) BR112013032224B1 (enExample)
CA (1) CA2838312C (enExample)
CY (1) CY1119417T1 (enExample)
DK (1) DK2720701T3 (enExample)
ES (1) ES2643843T3 (enExample)
HR (1) HRP20171431T1 (enExample)
HU (1) HUE036720T2 (enExample)
IL (1) IL229690A (enExample)
LT (1) LT2720701T (enExample)
MX (1) MX351895B (enExample)
PL (1) PL2720701T3 (enExample)
PT (1) PT2720701T (enExample)
RS (1) RS56394B1 (enExample)
RU (1) RU2625760C2 (enExample)
SI (1) SI2720701T1 (enExample)
SM (1) SMT201700470T1 (enExample)
TW (1) TWI592160B (enExample)
WO (1) WO2012172411A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014183047A1 (en) * 2013-05-10 2014-11-13 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
GB201402457D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Capsules containing high doses of phospholipids
GB201402450D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Liquid phospholipid-containing compositions for preperation of pharmaceuticals
GB201407345D0 (en) 2014-04-25 2014-06-11 Aker Biomarine As Krill Phospholipid compositions
US10898525B2 (en) 2014-04-30 2021-01-26 Aker Biomarine Antarctic As Krill oil preparations and their uses
US11147841B2 (en) 2014-12-19 2021-10-19 Aker Biomarine Antarctic As Enhanced omega-3 formulations
HK1250632A1 (zh) * 2015-03-31 2019-01-11 费森尤斯卡比德国有限公司 用於肠胃外给药的乳液
CN105901740A (zh) * 2016-04-26 2016-08-31 济南极源生物科技有限公司 一种南极磷虾油可食用营养品
JP7370317B2 (ja) * 2017-08-10 2023-10-27 ザ チルドレンズ メディカル センター コーポレーション 魚油および/またはオメガ3脂肪酸を含むエマルジョンに関する方法および組成物
EP3536332A1 (en) * 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
KR102451162B1 (ko) * 2020-09-07 2022-10-06 (주)에스디생명공학 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
JPH08231391A (ja) * 1995-02-24 1996-09-10 Kanagawa Kagaku Kenkyusho:Kk 痴呆症状改善薬
JP4761093B2 (ja) * 1997-12-10 2011-08-31 シクロスポリン セラポイティクス リミテッド オメガ−3脂肪酸油を含む医薬組成物
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
ES2386841T3 (es) * 2001-06-18 2012-09-03 Neptune Technologies & Bioressources Inc. Extractos de krill para la prevención y/o el tratamiento de enfermedades cardiovasculares
US7666447B2 (en) * 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
CN101321477A (zh) * 2005-10-07 2008-12-10 加拿大海洋营养食品有限公司 脂肪酸盐及其制备和使用方法
ZA200904176B (en) * 2006-11-16 2010-08-25 Pronova Biopharma Norge As Process for production of Omega-3 rich marine phospho-lipids from krill
EP2144618B2 (en) 2007-03-28 2024-11-20 Aker Biomarine Antarctic As Bioeffective krill oil compositions
WO2008140026A1 (ja) * 2007-05-11 2008-11-20 Bizen Chemical Co., Ltd. 新規のロイコトリエン受容体アンタゴニスト
NO327925B1 (no) * 2007-06-25 2009-10-19 Pharmalogica As Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene.
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
US8241672B2 (en) 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
AU2009354456B2 (en) * 2009-10-30 2014-05-08 Tharos Ltd Solvent-free process for obtaining phospholipids and neutral enriched krill oils

Similar Documents

Publication Publication Date Title
JP2014517028A5 (enExample)
RU2014138996A (ru) Гормонсодержащая эмульсия
ES2768091T3 (es) Uso del éster etílico del ácido eicosapentaenoico para tratar la hipertrigliceridemia
Nicholson et al. The role of marine n-3 fatty acids in improving cardiovascular health: a review
JP5864735B2 (ja) 非経口オキアミ油の治療用途
Ceylan et al. Wheat germ oil nanoemulsion for oil stability of the cooked fish fillets stored at 4 C
RU2011141102A (ru) Обогащенные омега-3 рыбные парентеральные питательные эмульсии типа масло в воде
PT2144618E (pt) Composições bioeficazes de óleo de krill
US20070122452A1 (en) Fat composition
BR112014016788A8 (pt) composições de ácidos graxos poli-insaturados ômega-3 em forma de ácido livre, enriquecidas com dpa
JP2013508296A5 (enExample)
Badiu et al. Effect of olive oil on the skin
JP2014505702A5 (enExample)
WO2011137160A3 (en) Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
DK2768316T3 (en) LIPID COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN PROBLEMS
RU2016129079A (ru) Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
Kindernay et al. Beneficial Effects of Polyphenol-Rich Food Oils in Cardiovascular Health and Disease
RU2016116835A (ru) Способы и композиции для улучшения функции почек
Wei et al. The potential of marine oils as functional foods: Nutritional composition, health benefits, applications, and future perspectives
WO2015050071A1 (ja) 栄養補助剤及び心血管疾患改善剤
Jarreau et al. Should we start prescribing omega-3 polyunsaturated fatty acids in chronic heart failure?
DiNicolantonio et al. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
Crawford Another Supplement for CAD Prevention Fails
JP6519875B2 (ja) 改良された魚油ベースのオメガ3補助食品